News About: Pharm. Industry
Amendment to tighten punishment for illegal rebates pass National Assembly
Incrementally adjusting the punishment on pharmaceutical and medical device companies providing illegal rebates to less than 3 years of prison or a less than KRW 30 million fine, the amendments to the Pharmaceutical A...
Listed pharmas earns KRW 75 by selling products worth of KRW 1,000
It was analyzed listed pharmaceutical companies generated KRW 75 products by selling products(goods and merchandises) worth of KRW 1,000 this year.
According to the Yakup Shinmoon’s(www.yakup.com) analysis result of ...
Will wholesalers be a key way to market products for pharmas after Kim Young-Ran Law?
While pharmaceutical companies suffering from difficulties in sales activities are seeking for new methods to generate sales after the Kim Young-Ran, they have started to actively use wholesalers.
It is true medical ...
Pharma industry paying sharp attention to prosecution’s addition investigation
Pharmaceutical companies have paid sharp attention to the result of the Novartis’ rebate case.
According to the pharmaceutical industry, while the trial for Novartis and some of the press is scheduled to be held on t...
Listed pharmas reduces R&D investments to overcome weakened profitability
Since some pharmaceutical companies’ profitability has been weakened, their short-sighted business management, which decreases investments in R&D, has been criticized.
According to the analysis result of the KOSPI an...
SK Chemicals’ hemophilia therapy ‘AFSTYLA’ on the way to enter EUOn the 15th, SK Chemicals(President Man-Hoon Park) announced the hemophilia treatment ‘AFSTYLA’ was recommended by the Committee for Medicinal Products for Human Use(CHMP), an a...
|
.jpg)
Listed pharmas’ poor performances in 3rd quarter
It was analyzed listed pharmaceutical companies had poor performances in the 3rd quarter. Their sales were a little above the annual average, and the profitability was weakened compared to the last year.
According to...
Hanmi Pharm diversifies volumes and dosage forms of Korean influenza drug ‘Hanmi Fly’So far, Hanmi Pharm has localized influenza treatments in Korea which had depended on foreign ones, and diversified their volumes and dosage forms.
On the 14th, Hanmi Pharm(CEO...
|
Dong Wha’s new phenomenon in working system with ‘AAFW’The Dong Wha Pharm’s management skill has attracted attention as implementing the working system which made its company culture more active.
According to Dong Who Pharm, the co...
|
.jpg)
Kim Young-Ran Law even changes outfits of pharmas’ medical representatives
The Kim Young-Ran Law, which prohibits corruption and bribery, is known to even change outfits of pharmaceutical companies’ medical representatives.
According to the industry concerned, the Anti-Corruption and Briber...
